CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Operating Lease, Liability, Noncurrent
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Operating Lease, Liability, Noncurrent of $407.71 million as of 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-05
- 2026-06-27: Operating Lease, Liability, Noncurrent $407.71M.
- 2026-03-28: Operating Lease, Liability, Noncurrent $393.11M.
- 2025-12-27: Operating Lease, Liability, Noncurrent $434.05M.
- 2025-09-27: Operating Lease, Liability, Noncurrent $443.19M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-27 | $407.71M 10-Q · filed 2026-08-05 |
| 2026-03-28 | $393.11M 10-Q · filed 2026-05-07 |
| 2025-12-27 | $434.05M 10-Q · filed 2026-08-05 |
| 2025-09-27 | $443.19M 10-Q · filed 2025-11-05 |
| 2025-06-28 | $453.66M 10-Q · filed 2025-08-06 |
| 2025-03-29 | $475.11M 10-Q · filed 2025-05-07 |
| 2024-12-28 | $483.79M 10-K · filed 2026-02-18 |
| 2024-09-28 | $432.84M 10-Q · filed 2024-11-06 |
| 2024-06-29 | $428.59M 10-Q · filed 2024-08-07 |
| 2024-03-30 | $418.05M 10-Q · filed 2024-05-09 |
| 2023-12-30 | $419.23M 10-K · filed 2025-02-19 |
| 2023-09-30 | $390.44M 10-Q · filed 2023-11-08 |
| 2023-07-01 | $401.63M 10-Q · filed 2023-08-09 |
| 2023-04-01 | $418.20M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $389.75M 10-K · filed 2024-02-14 |
| 2022-09-24 | $368.85M 10-Q · filed 2022-11-02 |
| 2022-06-25 | $365.77M 10-Q · filed 2022-08-03 |
| 2022-03-26 | $264.36M 10-Q · filed 2022-05-04 |
| 2021-12-25 | $252.97M 10-K · filed 2023-02-22 |
| 2021-09-25 | $244.01M 10-Q · filed 2021-11-03 |
| 2021-06-26 | $239.48M 10-Q · filed 2021-08-04 |
| 2021-03-27 | $173.01M 10-Q · filed 2021-05-04 |
| 2020-12-26 | $155.59M 10-K · filed 2022-02-16 |
| 2020-09-26 | $146.58M 10-Q · filed 2020-10-29 |
| 2020-06-27 | $147.35M 10-Q · filed 2020-08-05 |
| 2020-03-28 | $133.44M 10-Q · filed 2020-05-07 |
| 2019-12-28 | $116.25M 10-K · filed 2021-02-17 |
| 2019-09-28 | $116.87M 10-Q · filed 2019-11-06 |
| 2019-06-29 | $108.31M 10-Q · filed 2019-07-31 |
| 2019-03-30 | $109.05M 10-Q · filed 2019-05-07 |
| 2018-12-30 | $111.57M 10-K · filed 2020-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |